TCR diversity – a universal cancer immunotherapy biomarker?

por McNeel, Douglas G.
Publicado 2016

B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA

por Rastogi, Ichwaku, McNeel, Douglas G.
Publicado 2023

Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination

por Becker, Jordan T, McNeel, Douglas G
Publicado 2013

Toll-like receptor agonist combinations augment mouse T-cell anti-tumor immunity via IL-12- and interferon ß-mediated suppression of immune checkpoint receptor expression

por Jeon, Donghwan, McNeel, Douglas G.
Publicado 2022

The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy

por Smith, Heath A., McNeel, Douglas G.
Publicado 2010

Monitoring Regulatory Immune Responses in Tumor Immunotherapy Clinical Trials

por Olson, Brian M., McNeel, Douglas G.
Publicado 2013

Sipuleucel-T: immunotherapy for advanced prostate cancer

por Olson, Brian M, McNeel, Douglas G
Publicado 2011

B lymphocyte mediated antigen presentation of plasmid DNA

por Colluru, Viswa Teja, McNeel, Douglas G
Publicado 2013

SSX expression and function in prostate cancer

por Bloom, Jordan E, McNeel, Douglas G
Publicado 2013

SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer

por Bloom, Jordan E., McNeel, Douglas G.
Publicado 2016

B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines

por Colluru, Viswa Teja, McNeel, Douglas G.
Publicado 2016

Vaccines as treatments for prostate cancer

por Rastogi, Ichwaku, Muralidhar, Anusha, McNeel, Douglas G.
Publicado 2023

Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells

por Rekoske, Brian, Smith, Heath A, McNeel, Douglas G
Publicado 2013

Immunization with a prostate cancer xenoantigen elicits a xenoantigen epitope-specific T-cell response

por Johnson, Laura E., Frye, Thomas P., McNeel, Douglas G.
Publicado 2012

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination

por Johnson, Laura E., Olson, Brian M., McNeel, Douglas G.
Publicado 2017

Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer

por Muralidhar, Anusha, Potluri, Hemanth K., Jaiswal, Tanya, McNeel, Douglas G.
Publicado 2023

FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab

por Scarpelli, Matthew, Zahm, Christopher, Perlman, Scott, McNeel, Douglas G., Jeraj, Robert, Liu, Glenn
Publicado 2019

Role of B cells as antigen presenting cells

por Rastogi, Ichwaku, Jeon, Donghwan, Moseman, Jena E., Muralidhar, Anusha, Potluri, Hemanth K., McNeel, Douglas G.
Publicado 2022

Infectious Tolerance as Seen With 2020 Vision: The Role of IL-35 and Extracellular Vesicles

por Sullivan, Jeremy A., AlAdra, David P., Olson, Brian M., McNeel, Douglas G., Burlingham, William J.
Publicado 2020

Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer

por McNeel, Douglas G., Eickhoff, Jens C., Wargowski, Ellen, Zahm, Christopher, Staab, Mary Jane, Straus, Jane, Liu, Glenn
Publicado 2018